SPONSORED CONTENT
The healthcare landscape is evolving rapidly, and with it, the need for stronger, smarter partnerships has never been greater. Covered entities are navigating a time of uncertainty, where operational challenges, regulatory scrutiny, and resource constraints are putting unprecedented pressure on healthcare organizations. That’s why
…SPONSORED CONTENT
Artificial Intelligence (AI) has become a buzzword in nearly every industry, but
…SPONSORED CONTENT
Date/Time: Monday, February 24 from 8:30-9:30AM PST
Location: Marina Ballroom D @ the Marriott Marquis (3rd Floor, South Tower)
Start your week at the 340B Coalition Winter Conference ’25 with the latest developments in the 340B
…SPONSORED CONTENT
The evolving landscape of pharmaceutical pricing and reimbursement models presents complex challenges for manufacturers and pharmacies. One of the most significant developments is the introduction of the Inflation Reduction Act (IRA) and its Maximum Fair Price (MFP) provisions, aimed at reducing drug
…SPONSORED CONTENT
It’s January, which means we’ve released our Top Ten Issues for 2025! The experts at Visante have provided insights into the most pressing issues and transformative opportunities in health system pharmacy for the
…
SPONSORED CONTENT
TIP: Use AI to optimize your health system’s 340B program.
Artificial intelligence (AI) is transforming healthcare, offering
SPONSORED CONTENT
Join Apexus at an upcoming webinar, Resolving 340B Noncompliance: From Reversals to Refunds, on Wednesday, January 15. This webinar will review different options available for resolving ineligible 340B purchases, including claim reversals, manufacturer repayments, and other options.
Our expert speakers will
…SPONSORED CONTENT
The 340B Drug Pricing Program offers significant savings to eligible healthcare organizations, enabling them to stretch scarce resources further and provide better services to their communities. However, ensuring your program captures the maximum potential savings and operates optimally requires close monitoring of
…
×
*Sign up for news summaries and alerts from 340B Report
